Exponent (EXPO) Expected to Post Earnings on Thursday

Exponent (NASDAQ:EXPO) is anticipated to post its Q2 2026 results after the market closes on Thursday, July 30th. Analysts expect Exponent to announce earnings of $0.55 per share and revenue of $144.9890 million for the quarter. Interested persons can check the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Thursday, July 30, 2026 at 4:30 PM ET.

Exponent (NASDAQ:EXPO) last released its quarterly earnings results on Thursday, April 30th. The business services provider reported $0.59 earnings per share for the quarter, beating the consensus estimate of $0.56 by $0.03. Exponent had a return on equity of 27.94% and a net margin of 18.07%.The business had revenue of $166.30 million during the quarter, compared to analysts’ expectations of $149.53 million. During the same quarter last year, the business posted $0.52 EPS. The firm’s revenue for the quarter was up 14.3% compared to the same quarter last year. On average, analysts expect Exponent to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Exponent Price Performance

NASDAQ:EXPO opened at $60.72 on Thursday. The company has a market cap of $2.95 billion, a price-to-earnings ratio of 28.24 and a beta of 0.72. Exponent has a 1 year low of $51.91 and a 1 year high of $81.95. The stock’s 50 day simple moving average is $58.97 and its two-hundred day simple moving average is $65.65.

Exponent Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Friday, June 5th were given a $0.31 dividend. This represents a $1.24 annualized dividend and a yield of 2.0%. The ex-dividend date was Friday, June 5th. Exponent’s payout ratio is currently 57.67%.

Insider Activity

In other Exponent news, VP Bradley A. James sold 2,000 shares of the business’s stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $57.47, for a total transaction of $114,940.00. Following the transaction, the vice president owned 1,105 shares in the company, valued at $63,504.35. The trade was a 64.41% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, VP Joseph Rakow sold 2,945 shares of the business’s stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $54.66, for a total transaction of $160,973.70. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 15,324 shares of company stock valued at $855,019 over the last ninety days. 1.60% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Exponent

Several hedge funds have recently added to or reduced their stakes in EXPO. UMB Bank n.a. raised its position in Exponent by 54.8% in the 4th quarter. UMB Bank n.a. now owns 904 shares of the business services provider’s stock worth $63,000 after purchasing an additional 320 shares during the period. Kestra Advisory Services LLC purchased a new position in shares of Exponent during the fourth quarter valued at approximately $78,000. nVerses Capital LLC purchased a new position in shares of Exponent during the fourth quarter valued at approximately $218,000. FORA Capital LLC purchased a new stake in shares of Exponent in the second quarter worth approximately $228,000. Finally, Elevation Point Wealth Partners LLC purchased a new stake in shares of Exponent in the fourth quarter worth approximately $234,000. 92.37% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms have commented on EXPO. JPMorgan Chase & Co. lowered their price objective on shares of Exponent from $95.00 to $80.00 and set an “overweight” rating for the company in a research report on Friday, May 15th. Weiss Ratings restated a “hold (c-)” rating on shares of Exponent in a report on Friday, July 17th. Finally, UBS Group restated a “neutral” rating and set a $75.00 target price on shares of Exponent in a research report on Tuesday, June 2nd. Two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $77.50.

About Exponent

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.